Home / Transcripts / Sociedad Química y Minera de Chile S.A. (SQM) · November 18, 2026

Sociedad Química y Minera de Chile S.A. (SQM) Earnings Call Transcript

November 18, 2026

New York Stock Exchange US Materials Chemicals earnings 29 min

Earnings Call Speaker Segments

Ricardo Ramos executive
#1

Thank you. Morning, everybody, and we appreciate your joining us. It's my pleasure to take you through what SQM Group achieved in the third quarter. Our performance stayed strong throughout our core business segments, delivering positive results versus a year ago, and we posted roughly $1.6 billion in net income over the first three quarters of this year — nearly four times the net income we reported for the corresponding stretch in 2025. Turning to lithium, demand trends remain encouraging in our view, and our confidence in this market's long-term growth prospects is very high. Even though today's lithium price sits well below the peak we saw in the second quarter, we still observe healthy growth in lithium demand. So because of that, it makes sense to anticipate higher prices before long. The growth in demand is getting a boost from EV uptake as well as from the rising amount of lithium used in each vehicle. With markets expanding outside China and battery energy storage systems playing a bigger role, our estimate is that worldwide lithium demand may rise roughly 30% in 2026, and we believe the market has the potential to exceed 3 million metric tons by 2030. Operationally and commercially, both lithium divisions came in at the level we had expected. Turning to iodine, we again posted strong results, helped by healthy demand in the market and favorable pricing. X-ray contrast media remained the main driver of demand for iodine and its derivatives. Backed by those applications, we anticipate worldwide iodine demand will rise by more than 3% in 2026 and again in 2027. Our focus stays on reinforcing our standing as a dependable supplier while pushing forward on operational efficiency and production capacity. Now turning to specialty plant nutrition—that business likewise showed solid commercial momentum in the third quarter. Sales were strong throughout our traditional markets. Still, elevated fertilizer prices have dampened customer demand. Consequently, we adjusted our outlook for full-year sales volume growth to roughly 5% above last year. Prices, in the meantime, have kept trending positively. Our attention stays on achieving strong operational and commercial results, keeping a long-term view, and upholding financial discipline. Thank you.

Joel Jackson analyst
#2

Hello, can you hear me?

Joel Jackson analyst
#3

Apologies, there was a slight delay. I'm sorry about that. Thank you for taking my questions. I'll go through them one at a time. Obviously we've seen some shift in the lithium market since the summer, with prices having declined, and there's plenty of worry regarding 2027. There's a question I'd like to pose, which is: of the 30% lithium demand growth you're projecting for this year that we're observing, what portion of that 30% has come from demand, meaning end-use consumption, and what portion from inventory building? Based on everything you know, what do you think demand growth will look like in '27?

Pablo Hernández analyst
#4

Hey Joel, Pablo Hernández here. As Ricardo has mentioned, we're very strong on demand for this year and for the years ahead. Of that 30%, we believe the majority has come from end customers, since as we've observed and as you've observed in the market, inventory levels have come down over the course of this year. On your question about 2027, we anticipate growth next year in the figures of approximately 2.5 million metric tons of demand, which would amount to somewhere in the 15% to 20% growth range.

Joel Jackson analyst
#5

Could you discuss what we're seeing in the market at present, and we all see the inventory figures, but we see the worries about 2027. With that 15% to 20% demand growth expected next year, how are you accounting for some of the ESS worries we've been seeing, whether that's weaker IRRs because of what's going on in China, or some penetration from sodium, and how has your ESS view changed relative to, say, six months ago?

Pablo Hernández analyst
#6

Yeah; we're still very strong on BSS demand. We expect growth of about 15% for the coming year; we remain very, very confident about demand on the BSS side; on your sodium-ion question, yes, we've seen this new technology developing. We firmly believe lithium is very well-positioned to continue growing in this space. Sodium-ion could eventually claim a modest slice of the market, sure — but when you weigh production cost and energy density, lithium still has built-in edges over sodium-ion.

Joel Jackson analyst
#7

So my final question ties everything together. You're projecting total lithium demand growth of 15% to 20% next year, and within that you see ESS demand up roughly 15% next year. That implies EV demand is also climbing about 15% — 15% to 20% — next year, right?

Pablo Hernández analyst
#8

Yep, you're basically in that same range, exactly.

Joel Jackson analyst
#9

Thanks a lot.

Lucas Ferreira analyst
#10

Hi everyone, appreciate the time. Turning to lithium market fundamentals, could you share your view on the inventory picture on the ground in China — across the various channels, at the ports, and upstream? How have those inventories moved over the past few months, and do you still view the market as tight? I'm also curious how much of the lithium price decline we've seen reflects sentiment more broadly — say, the downward revisions to growth rates — versus, in your view, being supported by fundamentals as well. On the SQM side, I'm wondering whether there are any updates to your production or sales expectations for this year. Could you also touch on '27 — what you're expecting for production and sales? Thanks so much.

Pablo Hernández analyst
#11

Hi Lucas, Pablo Hernández here. Regarding your lithium question, as you said, 2026 did bring quite significant price swings, with prices naturally under the levels we saw around mid-year. As Ricardo said, demand remains very strong for us. We have a lot of confidence in growth over the coming years. Ricardo said demand should exceed 3 million metric tons by 2030, which shows just how much lithium will be needed in only the next few years. On top of that, demand right now is stronger—more robust than what we saw a few years back. Two major drivers exist today: EVs and BSS. Beyond that, demand is also more diversified from a global standpoint, which of course helps cushion particular market swings. Lastly, it's worth keeping in mind that today's prices appear to sit under the incentive level needed to attract fresh supply to meet this demand. So we ought to anticipate some price increase down the road.

Carlos Diaz analyst
#12

Hi, Carlos Díaz here. I'll be covering Novandino division production for this year and the next. For quarter three, we achieved output of nearly 75,000, which was fairly comparable to what we hit in quarter two. Across this year, we anticipate generating approximately 290,000 metric tons, entirely sourced from Salar de Atacama, and looking to next year, we aim to keep expanding our efficiency initiatives, boost recovery rates and so forth, plus additional efforts, so that output lands slightly above 300,000.

Lucas Ferreira analyst
#13

Many thanks.

Ben Isaacson analyst
#14

Thanks so much. Is my voice coming through clearly?

Ben Isaacson analyst
#15

I'll speak up. I have three questions. First question: if prices remain at their current levels, Gerardo, would the pace or timing of your capex spending shift? Would you begin postponing it, and would the way it's financed change too?

Ricardo Ramos executive
#16

Hi Ben, this is Ricardo Ramos. About our capex, which I think we discussed during the last conference call we had, it remains unchanged. In today's price environment, we don't see any reason to change our capital expenditure. We're feeling very, very optimistic about what's ahead, and our capex is closely focused on the areas where we think we have real competitive advantages.

Ben Isaacson analyst
#17

Thanks. Moving on to lithium sulfate, what run rate ought we to assume going forward? Given that the economics of your plant and tolling look comparable, what's the reason for needing the plant at all? Why not simply rely on tolling for 100%?

Carlos Diaz analyst
#18

This is Carlos Díaz once more. On lithium sulfate output, we're expecting 160,000 this year, roughly the same as 80,000 in lithium carbonate terms. Come next year, we anticipate raising that output somewhat. Right, we continue to operate our own factory in China, where we turn out over 20,000 in lithium carbonate terms, and the remaining output comes via tollers in China. We're constantly assessing ways to expand capacity in China or in Chile, and a few options are always under evaluation. No decision has been made as yet.

Ben Isaacson analyst
#19

One final question from me on SPN. Volumes declined, and you mentioned farmers pushing back somewhat against higher prices. Could you shed some light and offer detail: which products specifically, was it all NOP, and in which regions did you observe that pushback in demand? Was it purely because NOP prices were elevated after what China did earlier in the year? Do you think it will normalize?

Juan Pablo Bellolio executive
#20

Pardon me, Ben, Juan Pablo here. Would you mind repeating the question? We missed the second part.

Ben Isaacson analyst
#21

Sorry about that. My question concerns SPN: which regions and products in particular drove the lower volumes, and do you think that demand will return?

Juan Pablo Bellolio executive
#22

Ben, what I'd say is that since we sell in just about every country — over 100 countries — our sales are quite diversified. Higher prices across various products have affected, I'd say, every market. It isn't the case that one specific market accounts for the volume decline. You also have to keep in mind that we sold a very large volume in Q2; if you look at Q2 versus Q3, the volume is roughly the same as last year, okay? In terms of our sales, for the full year we're actually still ahead of last year. Q3 might be something exceptional, and we expect Q4 to be more or less in line with what we saw last year. As for higher prices and which products, naturally phosphates are the ones that are, I don't know, driving the biggest increase, affecting our distribution sales of phosphate products, but also the NPKs that use phosphate; those products, I'd say, are the ones with the largest impact. That's why we've offset this with higher sales of potassium nitrate, our main product; on the question about MOP, you need to remember that our potash business line covers MOP, but also SOP. The SOP price has risen during the year, and the share of SOP today is higher than in the past year, so that's why you're seeing that price increase.

Ben Isaacson analyst
#23

Thanks so much.

Corinne Blanchard analyst
#24

Hi there, good morning everyone. I appreciate you taking my question. I'd like to return to the International Lithium division regarding Mt. Holland. Could you provide a bit more detail or clarity about the expected volume for 2027? Since, from what you've said so far, it sounds like 4Q will be a solid step-up compared with the remainder of the year. I'm just wondering whether that carries on into 2027.

Mark Fones executive
#25

Hello Corinne, Mark Fones here. For this year, our production guidance for the concentrator at Mt. Holland remains within the same range of 175,000 to 185,000 tons of spodumene concentrate 6%. It is presently running at nameplate capacity, or perhaps a touch above nameplate capacity, and we anticipate the plant will keep operating on that basis next year. How much will be sold directly from that is still an open question, given our ramp-up into nameplate for the refinery, and that plan is being worked out right now; as soon as we have a clearer picture, we'll let you know in due course.

Corinne Blanchard analyst
#26

All right, so moving to the second part — and apologies if this has already come up — but regarding potash, what's the plan there across 2027 and 2028? I believe you said earlier that there would be no potash volume because of the strategy on the lithium side. Could you give us a clearer picture of the timing and how we should think about those volumes for next year and 2028?

Carlos Diaz analyst
#27

Sorry, apologies. Hello, yes? Sorry. Hello?

Carlos Diaz analyst
#28

Corinne, this is Carlos Díaz from the Novandino division; at Novandino our main focus is producing lithium, and potash is essentially a second product, or a byproduct, and we concentrate mainly on making potassium nitrate. Whenever there's potash left over, the fertilizer division is able to sell it on the market — I'll turn it over to Pablo so he can add something on that.

Juan Pablo Bellolio executive
#29

Yes, not much for me to add, but Carlos is correct. What matters is understanding that we hold a contract with Novandino that guarantees potash availability for our potassium nitrate business, which is the core business within the agriculture business. So, depending on production — how production goes — and whether we have potash available for direct sales, we'll keep doing that, because we have all the commercial offices in place to handle it, our port, and so forth. If availability exists, we'll keep selling that product.

Corinne Blanchard analyst
#30

Many thanks.

Isabella Simonato analyst
#31

Thanks. Good afternoon, all. Appreciate the call and for taking my question. I'd like to circle back a bit on the lithium side. I get your constructive stance, right, regarding the market and demand growth, but looking more at the short term, right, and with prices declining, I'm curious whether you have any sensitivity or view, right, on whether we might see prices settle at a lower level before rising, or when you'd anticipate some kind of inflection point as the demand story keeps unfolding in 2027? Thanks.

Pablo Hernández analyst
#32

Hi Isabella, it's Pablo Hernández here. Like I said earlier, prices are indeed well below where we saw them in the middle of the year, but naturally we stay very confident about demand, and we can't say when prices will go up, though we certainly expect an increase in the near future.

Isabella Simonato analyst
#33

Thanks. A quick follow-up on the potash side, right, I think we get that you're structurally lowering potash volumes, but could you give us a sense of maybe how much we can expect for the full year 2027 when it comes to potassium chloride volumes?

Juan Pablo Bellolio executive
#34

Hi Isabella, Juan Pablo here. We're still reviewing with our partners at Novandino our availability of commercial potash to bring to market. Naturally, we believe that, as we've been commenting and saying previously, volumes are going to decline. We don't know at what level yet, but you can, I don't know, take it that what we've been selling this year will be higher than next year.

Isabella Simonato analyst
#35

Thanks so much.

Matheus Moreira analyst
#36

Hello, good morning, and I appreciate you taking my questions. I have a couple of things to ask. First, regarding capex, the disbursements have been fairly light across the last few quarters, with year-to-date capex under $500 million. I'm curious what explains this capex that came in below expectations? Is it possible the company is tweaking spending to account for these harsher conditions, and how should we think about capex over the coming quarters? That's my first one. My second question concerns lithium, where costs were the negative surprise versus our figures this quarter. Since production was basically in line with what we had modeled, we'd have anticipated somewhat better cost performance. Can you help us understand what mainly drove the cost performance in the third quarter, and what we should look for on costs going forward? Then, if there's room for one last question about your mix, particularly within the International division, you've got the Mt. Holland expansion coming over the next couple of years and you're also ramping up the refinery in China, so I'm wondering what the ideal split between spodumene and hydroxide would be over the next couple of years in the International division? Those are my questions, thank you.

Gerardo Illanes executive
#37

Hi Matheus, Gerardo here. On your capex question, it's correct that through the first three quarters of this year capex came in a little under $500 million. What we shared last quarter is that we anticipate capex across the three years '26 to '28 to land in the neighborhood of $3 billion. That works out, on average, to $1 billion per year. For 2026, it will be somewhat below that level, but the projects continue advancing according to the schedule each one has, and so far we haven't made any changes to the capex plan.

Carlos Diaz analyst
#38

Regarding the lithium cost at the Novandino division, what I can tell you is that we've managed to hold on to our highly competitive cost position, bringing our cost down versus the prior year. Our third-quarter cost is pretty much in line with what we saw in the second quarter, and we're anticipating roughly the same cost for the fourth quarter. In fact, next year should again be at that same level. We aren't expecting any cost increase despite inflation and energy costs, since we've succeeded in cutting costs and boosting productivity so as to keep our production cost aligned. Once more, it will be lower than last year.

Matheus Moreira analyst
#39

Great, that's very clear. Thank you, Gerardo.

Mark Fones executive
#40

Matheus, regarding the International Lithium division, our costs have stayed stable across recent quarters. Our business is well-positioned in this market context. As I said earlier, the mine and concentrator are operating at full capacity, with competitive costs matching those of top Western Australian producers. The expansion will also bring us further reductions in unit costs going forward. I gather there was another question from you, but we couldn't hear it very well, so feel free to follow up.

Matheus Moreira analyst
#41

No, the last question concerned the mix within the International division between spodumene and hydroxide, given the Mt. Holland expansion over the coming few years and the Chinese refinery ramping up, so how do you expect that mix of spodumene versus hydroxide sales to develop?

Mark Fones executive
#42

Yes, like I said earlier, we're committed to ramping up lithium hydroxide. That ramp-up is going well. Product quality is already very good where battery-grade is concerned, and it keeps improving month by month. How exactly that distribution breaks down, whether it gets consumed by the Kwinana refinery or sold directly as spodumene concentrate, as I mentioned earlier, that remains a matter of planning and budgeting season for Covalent, and we'll duly inform everyone once we have a clearer picture for next year.

Matheus Moreira analyst
#43

That's clear. Thank you.

Operator operator
#44

Thank you very much. Ladies and gentlemen, that brings our Q&A session and conference for today to a close. We appreciate your participation, and you are welcome to disconnect now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Sociedad Química y Minera de Chile S.A. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to Sociedad Química y Minera de Chile S.A. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.